Overview

Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of GCS-100 and the biologic activity of GCS-100 in subjects with chronic lymphocytic leukemia.
Phase:
Phase 2
Details
Lead Sponsor:
La Jolla Pharmaceutical Company